ArticleMolecular and cellular biochemistry2026

Integrated in silico and in vivo approaches reveal naltrexone as a synergistic modulator of TLR4 and μ-opioid receptors restoring redox homeostasis via Nrf2/Keap-1/HO-1 and HIF-1α/VEGF pathways in COPD.

Soni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.